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A B S T R A C T
Pheochromocytoma is known from a wide range of clinical manifestations and can mimic other
disorders which can lead to delay in diagnosis. We report a case of a young female presenting with chest
pain, electrocardiographic changes, and episodes of ventricular tachycardia, ﬁnally diagnosed with this
catecholamine-producing tumor.
<Learning objective: Pheochromocytoma is a rare catecholamine-producing tumor that can pose a
diagnostic challenge due to its multiple manifestations mimicking various conditions, including
cardiovascular disorders. Despite its infrequent occurrence, pheochromocytoma should be considered as
a possible cause of life-threatening cardiac arrhythmias and electrocardiographic changes in patients
with diagnostic difﬁculties and primarily suspected of having cardiovascular disease. Furthermore, the
method of treatment is entirely different.>
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Pheochromocytoma is a rare and most often adrenally located
catecholamine-producing tumor with diverse and vicious clinical
manifestations and thus difﬁcult to diagnose. Typically it expresses
itself as a triad of abrupt episodes of headache, palpitations, and
profuse sweating, accompanied by either sustained or paroxysmal
hypertension or a labile blood pressure [1]. However, several case
reports illustrate unexpected onset of the disease with failure
of organs and systems, including multiple organ failure, as well
as severe cardiovascular disorders, including life-threatening
arrhythmias [2–9].
Case report
A 37-year-old healthy woman, smoker, with a family history of
coronary artery disease (CAD), was admitted to our department
with exercise-induced palpitations and chest discomfort. She
complained about similar episodes increasing in frequency and
severity over the previous year. Over the previous six months the
episodes occurred several times a week, and lasted for 5–15 min.
Three months prior to the admission, she was examined with
echocardiography and an ambulatory Holter monitoring, and both
tests were normal.* Corresponding author. Tel.: +45 52528851; fax: +45 97640888.
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objective examination. Electrocardiography (ECG) showed sinus
rhythm 75/min and negative T waves in V1–V5 (Fig. 1A).
Additionally, slightly elevated cardiac biomarkers with maximum
troponin T (TNT) 26 ng/l (reference: <14 mg/l) and maximum
creatinine kinase-MB (CK-MB) 6.6 mg/l (reference: <4.0 mg/l) led
to subacute coronary angiography (CAG), which was normal. The
remaining blood tests were normal and so were echocardiography,
cardiac rhythm monitoring during hospitalization, and exercise
test. ECG was normalized over the observation period (Fig. 1B).
During the ﬁrst admission she was normotensive (blood pressure
ranged from 100/55 mmHg to 145/90 mmHg) and did not
complain of symptoms characteristic for pheochromocytoma.
Finally, her episodes were attributed to suspected paroxysmal
supraventricular tachycardia, and she was discharged with a
planned ambulatory ECG monitoring (R-test) in order to detect
arrhythmia and a cardiac magnetic resonance imaging (MRI) to
disclose possible ischemic changes.
Two months later, the patient was readmitted with similar
symptoms, with exercise-induced palpitations and severe chest
pain. On admission she was pale and hypotensive at 90/53 mmHg.
Her pulse was 67/min, respiratory rate was 18/min, O2Sat 100%,
and temperature was 36.7 8C. The physical examination was
normal. An arterial blood gas analysis showed respiratory alkalosis
with a decrease in PaCO2 due to hyperventilation, an increased
plasma lactate 5.8 mmol/l (reference: 0.5–2.5 mmol/l), and plasma
glucose 12.8 mmol/l (reference: 4.2–7.8 mmol/l). Renal, liver, and
cholesterol blood samples were all normal. The initial ECG showeds reserved.
Fig. 1.
Electrocardiogram (ECG) and R-test tracing. (A) ECG on the ﬁrst admission mimicking evolved anterior wall myocardial infarction with negative T waves in V1–
V5. (B) Prior observed ECG changes normalized during the observation period. (C) ECG on the second admission showing generalized ST-segment depressions of
maximum 2 mm in V3–V4. (D) R-test tracing illustrating episodes of non-sustained polymorphic ventricular tachycardia. (E) ECG during an episode, showing
nodal rhythm with non-sustained polymorphic ventricular tachycardia. (F) ECG during another episode, showing exclusively nodal rhythm.
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maximum 2 mm in V3–V4 (Fig. 1C). An echocardiography revealed
slightly reduced left ventricular ejection fraction (LVEF) with
hypokinesia in the basal parts of the septum and the inferior wall.
The chest X-ray was normal. The patient’s symptoms, electrocar-
diographic and echocardiographic changes, as well as elevated
cardiac biomarkers, maximum TNT 415 ng/l and maximum CK-MB
12.8 mg/l, led to the suspicion of non-ST-segment elevation
myocardial infarction (non-STEMI) and the patient underwent
subacute CAG. The examination again ruled out CAD and coronary
vasoconstriction as possible causes of the symptoms. To ouradvantage, the day before the second admission, she had an
ambulatory R-test that revealed frequent episodes of an aggressive
non-sustained ventricular tachycardia (VT) 250/min, resembling
torsades de pointes (Fig. 1D). A diagnostic electrophysiological
study was performed without induction of the arrhythmia, despite
aggressive stimulation protocols and even despite high doses of
isoprenaline intravenously. Presence of an accessory pathway was
ruled out. Subsequent cardiac MRI conﬁrmed slightly reduced LVEF
at 55% and a suspicion of regional ischemic lesion, corresponding
to right coronary artery supply area. During the second hospitali-
zation, we reported further symptomatic episodes of VT as well as
Fig. 2.
Blood pressure ﬂuctuations during the ﬁrst week of the second hospitalization. Graph illustrating labile blood pressure with episodes of paroxysmal hypertension
of up to 224/125 mmHg.
Fig. 3.
Computed tomography (CT) scan of the abdomen and metaiodobenzylguanidine scintigraphy. (A) CT scan of the upper abdomen revealing an approximately
33 mm  32 mm  35 mm large tumor of the left adrenal gland. (B) Metaiodobenzylguanidine scintigraphy demonstrating a pathological uptake by the left
adrenal mass.
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pressure, ranging from 86/65 mmHg to 224/125 mmHg (Fig. 2).
Differential diagnostics led to the suspicion of pheochromocytoma,
which was supported by observed episodes of pallor and profuse
sweating related to the events.
Pheochromocytoma was conﬁrmed by elevated levels of plasma
metanephrines 1377 ng/l (reference: <90 ng/l), plasma 3-norme-
tanephrines 296 ng/l (reference: <180 ng/l), and by a 24-h urine
sample that showed an elevated urine epinephrine of 2208 nmol/l
(reference: <125 nmol/d), and a normal urine norepinephrine of
513 nmol/l (reference: <620 nmol/d). An abdominal computed
tomography scan revealed an approximately 33 mm  32 mm 
35 mm large tumor in the left adrenal area (Fig. 3A), and the
metaiodobenzylguanidine scintigraphy demonstrated uptake by
the left adrenal mass (Fig. 3B) and simultaneously ruled out
metastases. The patient was successfully treated with phenoxy-
benzamine, followed by beta-blocker. Three weeks later, she
underwent endoscopic retroperitoneal adrenalectomy. Histopato-
logical examination conﬁrmed the diagnosis of benign pheochro-
mocytoma. The patient has been asymptomatic to date.
Discussion
Our case report illustrates how difﬁcult the diagnosis of
pheochromocytoma may be, if a patient with this rare clinical
condition presents with atypical symptoms.
In patients with hypertension, an estimated prevalence of
pheochromocytoma is 0.1–0.6% [4,5]. Accurate data reporting the
incidence of life-threatening arrhythmias in this group of patients
are not available [10]. Only few cases describing pheochromocy-
toma-related monomorphic or polymorphic VT have been reported[2–10]. Moreover, patients with pheochromocytoma may present
with a variety of non-speciﬁc symptoms, which can obscure or
delay correct diagnosis. In our patient, initial clinical presentation
with episodes of abrupt palpitations and chest discomfort pointed
at paroxysmal supraventricular tachycardia, while afterwards
occurring chest pain with concomitant ECG changes mimicked
non-STEMI. Consequently, the patient underwent several inves-
tigations, including an invasive electrophysiological study and CAG
twice in a short time, and was exposed to potential complications.
As we excluded structural heart disease as an etiology of VT, one of
the diagnoses of exclusion was pheochromocytoma. Typical
symptoms of pheochromocytoma occurred late in the diagnostics
process, after the performance of invasive diagnostics during the
second hospitalization. Finally, imaging modalities and positive
speciﬁc biomarkers conﬁrmed the disease.
Pheochromocytoma may primarily manifest itself as a life-
threatening and demanding aggressive treatment cardiovascular
disorder. The tumor can lead to a dissecting aortic aneurysm,
cardiogenic shock, acute heart failure, catecholamine-induced
myocarditis, or cardiomyopathies, including Takotsubo cardiomy-
opathy [2–4]. Others have reported pheochromocytoma causing an
acute myocardial infarction, both in patients with and without
atherosclerosis [3,5]. Moreover, this neuroendocrine tumor can be
associated with a wide range of ECG changes, such as ST-T segment
deviations, as in our patient, or with prolongation of the QT
interval. Furthermore, several arrhythmias have been reported
from asystolic arrest and nodal rhythm to supraventricular and
ventricular tachyarrhythmias, including VT, torsades de pointes, or
even ventricular ﬁbrillation [2–9]. Thus, palpitations, reported by
approximately 50–70% of all patients with the tumor [3], can
indicate one of the life-threatening arrhythmias, as seen in our
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the blood, stimulated the b1-receptors and induced an aggressive
VT, whereas observed episodes with nodal rhythm illustrated the
body’s homeostatic mechanisms with increased vagal tonus and
reﬂex bradycardia in response to an abrupt rise in blood pressure.
The effects of catecholamines on different organs are deter-
mined by both their blood concentration and the types of the
adrenergic receptors in the organs. While in healthy individuals
catecholamines lead to vasodilatation of coronary arteries, in order
to cover increased oxygen demand under stress, in patients with
pheochromocytoma they may lead to vasoconstriction. This is a
result of catecholamine overload and thus excessive stimulation of
a-receptors. Concomitant b1-receptor stimulation inducing posi-
tive inotropic and chronotropic effects may lead to myocardial
ischemia or even infarction.
Our patient presented with chest pain and generalized ST-
segment depressions. She underwent CAGs that ruled out
atherosclerosis and vasospasm. Thus, the subendocardial ischemia
observed in the cardiac MRI might be secondary to the increased
myocardial oxygen demand and the direct toxic effects of
catecholamine oxidation products, inducing injury to cardiomyo-
cytes and their apoptosis [2–4]. An alternative explanation for the
abnormal ECGs on both admissions could be cardiac memory
phenomenon. The ST-segment depressions and inverted T waves
could reﬂect cardiac memory in a post-tachycardia syndrome after
paroxysmal episodes of VT. Similar changes are observed in
patients with ventricular pacing. The differentiation of ECG
changes due to cardiac memory and those caused by myocardial
ischemia can be challenging [11].
In the presented case, several short runs of VT accompanied by
the paroxysmal nature of the symptoms and ﬂuctuating blood
pressure, as well as exclusion of particular cardiovascular condi-
tions, led to the diagnosis of pheochromocytoma. This rare clinical
entity is usually a diagnostic challenge when a patient presents with
atypical symptoms, although it should be kept in mind as possible
etiology of acute ECG changes and cardiac arrhythmias.Conﬂict of interest
None declared.
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